0000899243-21-035000.txt : 20210902 0000899243-21-035000.hdr.sgml : 20210902 20210902205243 ACCESSION NUMBER: 0000899243-21-035000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brandenberger Ralph CENTRAL INDEX KEY: 0001853197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 211234920 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-582-4923 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-01 0 0001787400 Nkarta, Inc. NKTX 0001853197 Brandenberger Ralph C/O NKARTA, INC., 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 2021-09-01 4 M 0 340 0.41 A 340 D Common Stock 2021-09-01 4 M 0 405 4.77 A 745 D Common Stock 2021-09-01 4 M 0 1358 3.89 A 2103 D Common Stock 2021-09-01 4 M 0 2037 3.89 A 4140 D Common Stock 2021-09-01 4 S 0 4140 32.08 D 0 D Stock Option (right to buy) 0.41 2021-09-01 4 M 0 340 0.00 D 2028-07-18 Common Stock 340 8047 D Stock Option (right to buy) 4.77 2021-09-01 4 M 0 405 0.00 D 2029-05-10 Common Stock 405 9595 D Stock Option (right to buy) 3.89 2021-09-01 4 M 0 1358 0.00 D 2029-09-05 Common Stock 1358 32142 D Stock Option (right to buy) 3.89 2021-09-01 4 M 0 2037 0.00 D 2029-09-05 Common Stock 2037 48213 D The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Sr. VP, Technical Operations /s/ Alicia Hager, as Attorney-in-Fact 2021-09-02